Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Akero Therapeutics Inc (NASDAQ: AKRO) closed at $26.16 in the last session, up 4.56% from day before closing price of $25.02. In other words, the price has increased by $4.56 from its previous closing price. On the day, 0.62 million shares were traded. AKRO stock price reached its highest trading level at $26.23 during the session, while it also had its lowest trading level at $24.71.
Ratios:
We take a closer look at AKRO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.25 and its Current Ratio is at 17.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on November 18, 2024, initiated with a Buy rating and assigned the stock a target price of $65.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.Cantor Fitzgerald initiated its Overweight rating on September 19, 2023, with a $69 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 02 ’25 when Young Jonathan sold 10,000 shares for $28.03 per share. The transaction valued at 280,330 led to the insider holds 218,083 shares of the business.
Jonathan Young bought 70,000 shares of AKRO for $1,947,400 on Jan 02 ’25. On Dec 16 ’24, another insider, Lamy Patrick, who serves as the Senior VP, Commercial Strategy of the company, sold 1,000 shares for $29.13 each. As a result, the insider received 29,130 and left with 34,258 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1825947008 and an Enterprise Value of 1145057664.
Stock Price History:
The Beta on a monthly basis for AKRO is -0.21, which has changed by 0.13110304 over the last 52 weeks, in comparison to a change of 0.24440956 over the same period for the S&P500. Over the past 52 weeks, AKRO has reached a high of $37.00, while it has fallen to a 52-week low of $15.32. The 50-Day Moving Average of the stock is -9.54%, while the 200-Day Moving Average is calculated to be 0.78%.
Shares Statistics:
According to the various share statistics, AKRO traded on average about 700.02K shares per day over the past 3-months and 1051000 shares per day over the past 10 days. A total of 69.61M shares are outstanding, with a floating share count of 58.32M. Insiders hold about 16.44% of the company’s shares, while institutions hold 97.65% stake in the company. Shares short for AKRO as of 1735603200 were 3309161 with a Short Ratio of 4.73, compared to 1732838400 on 3287084. Therefore, it implies a Short% of Shares Outstanding of 3309161 and a Short% of Float of 4.8800003.
